Pragmat Obs Res. 2025 Dec 20;16:265-277. doi: 10.2147/POR.S562743. eCollection 2025. ABSTRACT OBJECTIVE: This study aims to identify predictive factors for […]
Arthritis Rheumatol. 2025 Dec 26. doi: 10.1002/art.70038. Online ahead of print. ABSTRACT OBJECTIVES: This study first identified the biallelic loss-of-function
Front Immunol. 2025 Dec 10;16:1675131. doi: 10.3389/fimmu.2025.1675131. eCollection 2025. ABSTRACT INTRODUCTION: Familial Mediterranean fever (FMF) and celiac disease (CD) are
J Clin Rheumatol. 2025 Dec 26. doi: 10.1097/RHU.0000000000002311. Online ahead of print. ABSTRACT BACKGROUND: Childhood-onset chronic nonbacterial osteomyelitis (CNO) is
Arthritis Rheumatol. 2025 Dec 26. doi: 10.1002/art.70040. Online ahead of print. NO ABSTRACT PMID:41451457 | DOI:10.1002/art.70040
Brain Behav Immun Health. 2025 Dec 2;50:101153. doi: 10.1016/j.bbih.2025.101153. eCollection 2025 Dec. ABSTRACT In Lyme disease (LD), 10-20 % of
Arthritis Rheumatol. 2025 Dec 26. doi: 10.1002/art.70045. Online ahead of print. ABSTRACT OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic
Neurohospitalist. 2025 Dec 23:19418744251408879. doi: 10.1177/19418744251408879. Online ahead of print. ABSTRACT Background: Systemic lupus erythematosus (SLE) is a multi-system autoimmune
‘Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said
Objective Deficiency of adenosine deaminase 2 (DADA2) is a monogenic autoinflammatory disease manifested as polyarteritis nodosa, stroke, and bone marrow
Ann Rheum Dis. 2025 Dec 24:S0003-4967(25)04549-2. doi: 10.1016/j.ard.2025.11.017. Online ahead of print. ABSTRACT OBJECTIVES: Sjögren’s disease (SjD) is clinically and
Stem Cell Res Ther. 2025 Dec 25. doi: 10.1186/s13287-025-04877-3. Online ahead of print. ABSTRACT BACKGROUND: The resolution of inflammation is
Ann Rheum Dis. 2025 Dec 24:S0003-4967(25)04536-4. doi: 10.1016/j.ard.2025.11.010. Online ahead of print. ABSTRACT OBJECTIVES: To evaluate temporal trends in treatment
BMJ Open. 2025 Dec 24;15(12):e082366. doi: 10.1136/bmjopen-2023-082366. ABSTRACT OBJECTIVES: Evaluate tofacitinib efficacy, safety and persistence by sex in rheumatoid arthritis
RMD Open. 2025 Dec 25;11(4):e006070. doi: 10.1136/rmdopen-2025-006070. ABSTRACT OBJECTIVES: To assess for the first time a combination of new and
BMJ Open. 2025 Dec 25;15(12):e097892. doi: 10.1136/bmjopen-2024-097892. ABSTRACT INTRODUCTION: Pain in patients with rheumatoid arthritis (RA) is an unmet clinical
BMJ Open. 2025 Dec 25;15(12):e105894. doi: 10.1136/bmjopen-2025-105894. ABSTRACT INTRODUCTION: Systemic sclerosis (SSc) is an autoimmune disorder causing progressive fibrosis of
J Clin Epidemiol. 2025 Dec 23:112118. doi: 10.1016/j.jclinepi.2025.112118. Online ahead of print. ABSTRACT OBJECTIVES: Incomplete reporting of research limits its
Bone. 2025 Dec 23:117769. doi: 10.1016/j.bone.2025.117769. Online ahead of print. ABSTRACT PURPOSE: This narrative review explores the therapeutic potential of
Metabolism. 2025 Dec 23:156485. doi: 10.1016/j.metabol.2025.156485. Online ahead of print. ABSTRACT BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the
J Allergy Clin Immunol. 2025 Dec 23:S0091-6749(25)02191-8. doi: 10.1016/j.jaci.2025.12.994. Online ahead of print. ABSTRACT BACKGROUND: Atopic dermatitis (AD) is a
Phytomedicine. 2025 Dec 19;150:157731. doi: 10.1016/j.phymed.2025.157731. Online ahead of print. ABSTRACT INTRODUCTION: Methotrexate (MTX), a cornerstone disease-modifying anti-rheumatic drug, exhibits
Exp Cell Res. 2025 Dec 23:114871. doi: 10.1016/j.yexcr.2025.114871. Online ahead of print. ABSTRACT The etiology of primary Sjögren’s syndrome (pSS)
… rheumatologists, and physical therapists. “People serving as PCPs … Rheumatology (ACR) 2025 Annual Meeting. Related Conditions & Procedures.
A report card on meeting goals of reducing activity and work limitations for people with arthritis delivers bleak news, but
Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of therapy, effectively reducing disease activity and improving health-related QoLÂ …
EBioMedicine. 2025 Dec 24;123:106095. doi: 10.1016/j.ebiom.2025.106095. Online ahead of print. NO ABSTRACT PMID:41447758 | DOI:10.1016/j.ebiom.2025.106095
